Arkolith/Insider Trading/VOR/Form 4

Ra Capital Management, L.P.

Director, 10% OwnerVor Biopharma Inc. (VOR) · full profile →Form 4 · filed Apr 15, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$11.9M
Net Open-Market Flow
-$11.9M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 15, 2026Sell(S)54K$16.01$859K3.2M
Apr 14, 2026Sell(S)154K$15.97$2.5M3.3M
Apr 13, 2026Sell(S)531K$16.15$8.6M3.4M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000355) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML